Given that only clinical trial data for PD-1 and CTLA-4 blockers are available, the data from testing blockers against other ICs (TIGIT, LAG-3, Tim-3, CD160, 2B4, BTLA, and VISTA) may prove highly useful in treatment of AIDs. This evidence concerns the gene TIGIT and AIDS.